Furthermore, a risk-factor driven element in GPVI-dimerization is evidenced from our results since AF, an inflammatory condition known to modulate platelet activity [24]; hypertension; diabetes; and a higher CHA2DS2-VASc score were all significantly associated with higher GPVI-dimer expression (Table 2). This evidence concerns the gene GP6 and atrial fibrillation.